Jyothy Labs (JYOTHYLAB) Q2 FY27 Profit Plunges 87.5% as Crude-Linked Costs Bite
The FMCG firm reported a 3.3% rise in Q2 FY27 revenue, but net profit collapsed due to severe raw material inflation, compressing margins to a multi-year low.
Jyothy Labs' Q2 FY27 earnings reveal a stark divergence: revenue grew 3.3% to ₹760 crore, but net profit collapsed 87.5% to ₹11 crore. Unprecedented inflation in crude-linked raw materials and packaging drove the sharpest margin contraction in recent history.
For Jyothy Labs, the September quarter was a story of a resilient core business running headlong into a historic cost storm. The company's flagship brands like Ujala and Exo delivered strong underlying growth, but that momentum was completely erased by an unprecedented surge in input costs.
The numbers tell a tale of two diverging trends. Revenue inched up 3.3% year-on-year to ₹760 crore. Yet, net profit collapsed to just ₹11 crore, down 87.5% from a year ago. The net profit margin shrank to 1.4%, a staggering 1,050 basis points lower than Q2 FY26.
Revenue & profit
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ2 FY27 | PreviousQ1 FY27 | Same quarter LYQ2 FY26 |
|---|---|---|---|
| Revenue (₹ Cr) | 760.0YoY +3.2% | 773.4 | 736.1 |
| Profit (₹ Cr) | 11.0YoY -87% | 47.6 | 87.8 |
| Net Profit Margin (%) | 1.4YoY -88% | 6.2 | 11.9 |
The Crude-Linked Squeeze
The collapse in profitability was driven by a 19.7% surge in total expenses. Management, in the earnings call, pinpointed “unprecedented increase in raw material and packaging costs” as the primary challenge. With 60-65% of its cost basket linked to crude derivatives, the company was hit hard by inflation in inputs like LABSA, SLES, soap noodles, and packaging materials.
Gross margin plummeted to 34.8% from 48.1% a year ago, as per the Investing.com transcript. A 4% price increase taken during the quarter was insufficient to bridge the gap. Higher freight, logistics, and employee costs further pressured the bottom line.
Underlying Strength Amid the Storm
Beneath the grim headline, the core business showed vigor. Excluding the discontinued Pril and Fa brands, underlying value growth was a healthy 12.4% with 8.1% volume growth, according to the company's presentation. Fabric care grew 10.4%, while home care (ex-Pril) and personal care grew over 15% and 11%, respectively.
This resilience gave management the confidence to announce a ₹147 crore share buyback, with promoters not participating. The board also reaffirmed its medium-term revenue target of ₹5,000 crore.
A Gradual Path to Recovery
The outlook hinges on commodity prices. CFO Pawan Agarwal called FY27 an “aberration year” driven by geopolitical factors, in the AlphaStreet transcript. Management expects a progressive, not immediate, margin recovery through multiple levers beyond pricing.
These include procurement efficiencies, value engineering, and improving the product mix toward items with lower crude dependency. The company's strong, debt-free balance sheet with ₹846 crore in cash provides the stamina to navigate this period.
Key Points
- Net profit fell 87.5% YoY to ₹11 crore, as a 19.7% rise in expenses crushed margins.
- Underlying business remained strong, with core portfolio value growth of 12.4% excluding discontinued brands.
- Management attributes the profit crash to historic inflation in crude-linked raw materials, which form 60-65% of the cost base.
- A ₹147 crore share buyback was approved, reflecting confidence in long-term fundamentals despite near-term pressures.
Hexa Perspective
The quarter lays bare Jyothy Labs' acute sensitivity to crude volatility. While the brand strength and volume growth are undeniable, the path back to double-digit margins is long and entirely dependent on external cost trends stabilizing.
Investors are weighing a robust, growing core business against a profitability profile that has vaporized in one quarter. The buyback offers support, but the stock's trajectory will be decided by the pace of margin recovery, which management itself admits will be gradual.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.
